DENTSPLY SIRONA, Inc. (XRAY)

In the past six months, Dentsply Sirona's stock has been impacted by several key events. The company reported a GAAP net loss per share of ($2.14) in Q3 2025. In Q4 2025, net sales increased by 6.2%, but a net loss was reported due to goodwill and intangible impairments; a restructuring initiative was announced, and a new capital allocation strategy was initiated. In Q1 2026, net sales were flat year-on-year but beat analyst expectations, and the company reiterated its full-year 2026 outlook for net sales and adjusted EPS. The stock price as of April 30, 2026, was $11.75 per share, representing a decline of 16.55% from May 2, 2025. As of May 8, 2026, the closing price was $10.98.

The variety of products in demand differs from region to region due to income disparity between wealthy and developing nations. The company operates in a corner of healthcare that consistently demands precision, selling to dental practices rather than directly to consumers, which shapes its revenue stability and growth expectations. The underlying dental market is generally stable.

Dentsply Sirona, Inc. is the world's largest diversified manufacturer of professional dental products and technologies, operating within the healthcare sector. The company develops, manufactures, and markets a comprehensive range of solutions, including dental equipment, dental products, and healthcare consumable products. Dentsply Sirona has been a pioneer in the dental industry, introducing various innovations such as the first dental electric drill and CAD/CAM system.

Dentsply Sirona has a significant global presence, marketing its products in approximately 150 countries and operating in more than 40 countries with factories in 21 countries. Its worldwide headquarters is located in Charlotte, North Carolina, with principal operations in the United States. As of full-year 2025, sales distribution was approximately 32% in the United States, 43% in Europe, and 25% in the Rest of World. The company's geographic regions for reporting net sales were revised in Q1 2026 to Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

Dentsply Sirona has a strong legacy of innovation and a commitment to sustainability. In 2024, the company invested approximately 4% of its revenue into R&D and launched 21 new products globally. Dentsply Sirona's sustainability strategy focuses on reducing its environmental footprint, fostering a diverse and inclusive culture, and ensuring integrity and transparency. Forbes also recognized Dentsply Sirona in 2026 as one of "America's Best Midsize Employers" and "America's Dream Employers" in the Medical Equipment & Services category.

Dentsply Sirona is primarily owned by institutional shareholders, with 100.04% institutional ownership. Major institutional owners include Vanguard Group Inc., BlackRock, Inc., and First Eagle Investment Management, LLC. Vanguard Group Inc. is the largest individual Dentsply Sirona shareholder, holding 21.86 million shares, representing 10.91% of the company.